Keyphrases
Cluster Headache
100%
Preventive Treatment
100%
Migraine Headache
100%
Calcitonin Gene-related Peptide
100%
Clinical Data
100%
Phase II Trial
83%
Monoclonal Antibody
33%
Therapeutic Potential
16%
Migraine
16%
New Drugs
16%
Multiple Phases
16%
Severely Affected
16%
Erenumab
16%
Eptinezumab
16%
Chronic Migraine
16%
Literature Search
16%
Headache
16%
Migraine Treatment
16%
Episodic Migraine
16%
PubMed
16%
Preventive Potential
16%
Antibody Targeting
16%
Galcanezumab
16%
Fremanezumab
16%
Drug Class
16%
Cardiovascular Effects
16%
Preventative Medicine
16%
Affected People
16%
Randomized Controlled Trial
16%
Pharmacology, Toxicology and Pharmaceutical Science
Cluster Headache
100%
Calcitonin Gene Related Peptide
100%
Migraine
100%
Monoclonal Antibody
50%
Randomized Controlled Trial
16%
Erenumab
16%
Galcanezumab
16%
Transformed Migraine
16%
Fremanezumab
16%
Headache
16%
Episodic Migraine
16%
Eptinezumab
16%